Melanocortin receptor agonists
US7314879B2 · kind B2 · utility
4Cited by
1References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2003 |
| Grant date | Jan 1, 2008 |
| Priority date | — |
| Expiry date | Jan 14, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to melanocortin receptor agonist of the formula (I): which is useful in the treatment for obesity, diabetes, and male and/or female sexual dysfunction
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.